Need help with Komen Fund Allocation Information

Options
JeninMichigan
JeninMichigan Member Posts: 2,974

I recently got into a Facebook discussion with NW Ohio Komen affiliate. I was stating that the amount of money they allocate to research pales in comparison to the amounts for awareness and education and that the amount dedicate to MBC pales in comparison to the total amount directed to research. if you want to see the whole thread it is NW Ohio Komen on Facebook. Following is her comment:

Jennifer, where are you seeing the statistic about less than 5%? That is either out of date or incorrect. Since our founding, Komen has devoted 18% ($157 million) of the total $889 million research dollars toward metastatic breast cancer. And that percentage is likely only going to increase. Last year nearly half of the research dollars spent by Komen national (with money raised by all the affiliates collectively) went to Metastatic research. 36 out of the 101 grants were devoted to metastatic breast cancer; more than any other breast cancer sub-type.

She wants me to cite my sources. I replied that in 2014-15 according to their website only 20 percent was directed to research. Does anyone have credible information as to the breakdown of the 20 percent.

Thanks

Jennifer

Comments

  • JeninMichigan
    JeninMichigan Member Posts: 2,974
    edited August 2016

    Thanks Kay.. What I am looking for is to confirm the percent of money directed towards MBC research.

  • JFL
    JFL Member Posts: 1,947
    edited August 2016

    Jenn, good luck tracking down the info. From what I have read they don't even spend 18% of their revenue on breast cancer research of any kind. A very low portion goes to research and most funds go to "awareness". I have no idea about mets research, which is very low

    When I was first diagnosed 10 years ago, I raised a lot of money for Komen in the beginning but quickly leaned more about their practices and diverted all my contributions to the Young Survival Coalition after that, which has a very low overhead and directly and significantly impacts young women with cancer through their programming, which I continue to benefit from year after year. I cannot say the same for Komen. It is a showy organization that tries to glamorize breast cancer with pink ribbons and boas. It is all about the branding, fame and being high profile and not enough focus on truly finding a cure. Okay, end of rant.

    Good for you for standing up to them on this issue! I hope you find the stats you are looking for.

  • Lynnwood1960
    Lynnwood1960 Member Posts: 1,284
    edited August 2016

    I just saw something on Facebook that Komen is linking itself to the Metastatic Breast Cancer Project. Did anyone else see this or know anything about it?

  • Tina2
    Tina2 Member Posts: 2,943
    edited August 2016

    Wow, Lynnwood. That's interesting. I'm not crazy about an organization with such a consistently poor record affiliating itself with the MBC Project unless it's to contribute a large amount of funding and then shut up about it. I'm certain that Komen will use any association with this innovative direct-to-patient study to promote itself and attempt to clean up its image. It's too easy. And it offends me.

    Tina

  • Lynnwood1960
    Lynnwood1960 Member Posts: 1,284
    edited August 2016

    Tina, I agree! I hate to see such a great project tarnished by the name of Komen . The article I read said they are making a large donation I take that exactly as you did, they are looking to clean up their image and promote themselves

  • Tina2
    Tina2 Member Posts: 2,943
    edited September 2016

    Here it is (I might add that $375,000 is chump change to Komen):

    Susan G. Komen Invests $375,000 in Metastatic Breast Cancer Research Project

    Funds Will Focus on Advancing Understanding of Metastatic Disease in Young Women as Part of Direct-to-Patient Research Study

    August 30, 2016 09:00 AM Eastern Daylight Time

    DALLAS--()--Susan G. Komen today announced a $375,000 commitment toward the innovative work of the Metastatic Breast Cancer (MBC) Project, which empowers patients to accelerate research and advance our understanding of metastatic breast cancer. Funds from Komen will be used to analyze samples from young women with metastatic breast cancer who have joined the MBC Project – helping to identify molecular and genetic features unique to younger patients with breast cancer.

    "This is an outstanding example of the important research being conducted by early-career investigators, and the power of investing in the next generation of breast cancer researchers"
    Tweet this

    Led by Dr. Nikhil Wagle and colleagues at the Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute, the MBC Project directly engages patients with metastatic breast cancer using social media and partnerships with advocacy organizations and empowers them to share their medical records and saliva and tumor samples to help expedite important discoveries. Since the project's launch in October of 2015, more than 2500 women and men with MBC, including from all 50 states and Canada, have enrolled in the study.

    "We are excited to support Dr. Wagle's work on this innovative project. This study will not only help improve our understanding of the disparities that exist for younger breast cancer patients, but also inform the development of new treatment strategies for metastatic breast cancer in this population," said Komen President and CEO Dr. Judy Salerno.

    "This is an outstanding example of the important research being conducted by early-career investigators, and the power of investing in the next generation of breast cancer researchers," Dr. Salerno added.

    In addition to supporting the MBC Project, Komen funding has helped catalyze Dr. Wagle's promising career in breast cancer research. Last fall, Komen awarded $450,000 to Dr. Wagle to utilize molecular and genomic studies to improve understanding of estrogen receptor-positive breast cancer that has become resistant to treatment.

    "We are incredibly grateful to have received this support from Susan G. Komen," Dr. Wagle said. "This grant will help us study the young women and men who have joined the Metastatic Breast Cancer Project, a group of patients who often present with more advanced and aggressive tumors. We are proud to have joined with these and many other metastatic breast cancer patients, advocates, and advocacy organizations to launch this patient-driven research project – and look forward to making strides in improving treatments for patients with metastatic breast cancer in partnership with the patient community."

    A collaborative effort across the breast cancer community, organizers at the Broad Institute and Dana Farber turned to advocacy organizations and patients to help design the MBC Project itself, working closely with a number of partner organizations.

    About Susan G. Komen®

    Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since its founding in 1982, Komen has funded more than $889 million in research and provided $1.95 billion in funding to screening, education, treatment and psychosocial support programs. Komen has worked in more than 60 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social

    About the Metastatic Breast Cancer Project

    The Metastatic Breast Cancer Project (MBCproject.org) is a research project launched by the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute that directly engages patients with metastatic breast cancer and empowers them to accelerate research by sharing their samples and clinical information. The goal is simple: to create a patient-researcher partnership to speed discoveries and the development of new treatments for metastatic breast cancer.

    Patients with metastatic breast cancer can sign up for the project by visiting MBCproject.org, clicking "Count Me In" and entering their name and email address. Since the project's launch in October 2015, more than 2,500 women and men with metastatic breast cancer have joined the study. The project was designed and implemented with the input of dozens of metastatic breast cancer patients, advocates, and advocacy organizations - and continues to actively engage the metastatic breast cancer community at every step. These organizations include the Metastatic Breast Cancer Network, the Metastatic Breast Cancer Alliance, Avon Foundation, Living Beyond Breast Cancer, Inflammatory Breast Cancer Research Foundation, Young Survival Coalition, SHARE, Male Breast Cancer Coalition, Theresa's Research Foundation, Triple Negative Breast Cancer Foundation, The IBC Network Foundation, Advocates 4 Breast Cancer, METAvivor, MET UP, Tigerlily Foundation, Susan G. Komen, Breast Cancer Research Foundation, Dr. Susan Love Research Foundation, Breast Cancer Social Media, and Hope Scarves.

    To learn more about the MBC Project and hear from patient-participants, please watch our short video.

    Contacts

    Susan G. Komen
    Joni Avery, 972-855-4382
    press@komen.org

    Susan G. Komen

    Release Summary

    Susan G. Komen today announced a $375,000 commitment toward the work of the Metastatic Breast Cancer (MBC) Project, which empowers patients to accelerate research and advance our understanding of MBC.

    Release Versions

    More NewsRSS feed for Susan G. Komen

    Contacts

    Susan G. Komen
    Joni Avery, 972-855-4382
    press@komen.org

  • Ally46
    Ally46 Member Posts: 12
    edited September 2016

    Shocking facts about Susan G. Komen for the Cure

    Pinktober is fast approaching and this year I'm launching a preemptive strike to combat the tidal wave of pink propaganda that's coming in a few weeks.

    I've assembled some of the most shocking facts about the world's largest "breast cancer awareness" charity organization: Susan G. Komen for the Cure.

    Only 21% of money that Susan G Komen for the Cure raises goes to cancer research "for the cure". Simple math tells us that 79% of the money they raise isn't going to anything that could produce a cure. As if that wasn't bad enough, donating to cancer research is essentially giving free money to drug companies who make billions in profit every year, and don't need your money, and are only interested in research that can lead to a patentable highly-profitable drug that they can sell back to you. For more on this, watch my 500k view rant Why I Don't Race for the Cure.

    -Komen has taken legal action against over 100 small non-profits for using the phrase "for the cure" in their fund-raising campaigns. How dare you sell cupcakes for the cure. Sue that little girl!

    -In 2010, Komen partnered with KFC who sold pink buckets of chicken "for the cure". Apparently the folks at Komen don't know that fast food consumption is directly linked to obesity, and that obesity is the 2nd leading cause of cancer.

    -In 2011, Komen created and sold a perfume called "Promise Me" containing potentially cancer-causing toxic ingredients coumarin, oxybenzone, and toluene. After criticism they pulled it from the market.

    -In 2012, Komen Founder/CEO Nancy Brinker was paid $684,717, a 64% increase from her $417,000 salary in 2011. And this was AFTER a big drop in donations and half their 3-Day races were canceled.

    -In 2012, Komen drew criticism from the medical community for using misleading statements and deceptive statistics in their ads promoting mammograms. Komen uses donation money to provide mammograms to women who can't afford them, which seems good, until you learn that a 25-year study of 90,000 women proved that mammograms don't save lives, and that what early detection campaigns are actually doing is overdiagnosing and funneling women into an industry of harmful overtreatment, resulting in unnecessary surgery, chemo, radiotherapy and hormone therapies.

    -In 2013, Komen partnered with Real Water to sell pink water bottles, even though disposable plastic water bottles contain BPA, which is linked to breast cancer tumor growth.

    -In 2014, Komen partnered with Baker Hughes to produce 1,000 pink drill bits to be used in their fracking operations with the cutesy slogan "Doing their bit for the cure". Fracking involves the use of 700 different chemicals, some of which, like benzene and formaldehyde, are linked to cancer.

    -As a result of some of the shenanigans above, in 2014, Charity Navigator downgraded Komen to 2 stars (out of 4). Since that public embarrassment, Komen has been working to improve their rating. Nancy Brinker stepped down and was replaced with a much lower paid CEO. Their overall rating has come back up to 3 stars, but their financial rating is still 2 stars as of June 2016.

    -Another organization that Komen funnels money to that has nothing to do with curing cancer is Planned Parenthood, which was founded by racist, eugenicist, sterilization proponent Margaret Sanger (google her) and is the single largest provider of abortions in the United States. Multiple studies (ignored by mainstream media) suggest that abortions significantly increase a woman's risk of breast cancer. I realized this might produce some anxiety for you, dear reader, but you need to know.

    In 2012, under the leadership of senior vice president of public policy Karen Handel, Komen's board made the announcement that they had voted to stop funding Planned Parenthood because PP was under investigation by the federal government. After a backlash from abortion supporters and a media firestorm, Komen reversed their position. Karen Handel resigned and authored a book about the whole affair entitled Planned Bullyhood: The Truth Behind the Headlines About the Planned Parenthood Funding Battle with Susan G. Komen for the Cure.

    And those are the reasons I have taken a firm position against donating to Susan G Komen for the Cure. I know that's a lot of heavy stuff, and I'm certainly not one to advocate dwelling on negativity, but we need to be aware of what's happening around us. If Komen changes their ways, my opinion of them could change as well.

    The BEST way to help cancer patients is to put CASH MONEY in their hands to help with groceries, gas, medical bills, supplements, rent, utilities, child care, etc.

    And that's what prompted the creation of the Pink Ribbons SCAM shirt, designed by yours truly, to raise awareness about Komen and to raise money for cancer patients. Proudly display your disdain for Komen and Pinkwashing and help spread the idea that we should "Give to patients not to Komen" (which is what the shirt says).

  • Lynnwood1960
    Lynnwood1960 Member Posts: 1,284
    edited September 2016

    It sure is chump change! Can't help but question their motive.

  • Becs511
    Becs511 Member Posts: 303
    edited September 2016

    Ironic timing, but I just saw a post on Facebook about Komen holding its' first annual Metastatic Breast Cancer Symposium this year. It is scheduled to take place this fall in Philadelphia. Here is a link to the press release.Komen MBC Symposium

  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    Hi Ally46 - that post you shared is from the highly unreliable Chris Beat Cancer website:

    http://www.chrisbeatcancer.com/shocking-facts-abou...

    While I'm all about alternatives, integrative and holistic practices, this website clearly has something to sell - including this merchandise:


    Pink Ribbons Scam ShirtPink Ribbons Scam tank top

    LIMITED RUN
    These shirts are only available until September 12th! They should arrive approximately 7 business days later, just in time for Pinktober.

    100% OF THE PROCEEDS GO DIRECTLY TO CANCER PATIENTS
    I make zero dollars and I will be paying for my own shirt. Everyone who purchases a shirt will be able to nominate someone for donation consideration. I'll send the shirt buyers a special email with instructions after the campaign has ended.

    More to come, Stephanie

  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    Am working on finding more reliable sources for the 5% figure and see that it's primarily based on this one study from the UK that is neither metastatic breast cancer specific nor recently updated.

    Cancer metastasis as a therapeutic target

    Unfortunately, the article is locked behind a paywall, so let's consult this related press release:

    Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients

    Date:
    June 1, 2010
    Source:
    ECCO-the European CanCer Organisation
    Summary:
    On average, about 5 percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer deaths, according to a new editorial.

    More later on Think Before You Pink, Pink Ribbons film, Breast Cancer Action and other contributors to this information that may be misinformation!

    I'm no apologist for Komen, but it's worth it to check out our facts and figures when we're trying to convince others of our correct understanding!

    Best wishes all, Stephanie
  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    Hi Ally46,

    I'm so sorry that I responded hastily and perhaps unkindly.

    Thank you for contributing to this conversation and others!

    We haven't met yet and I see that you've made only 7 posts at bco.

    Please accept my apologies and please continue sharing what matters to you.

    Slowing down now, Stephanie

  • JFL
    JFL Member Posts: 1,947
    edited September 2016

    Ally, interesting you mention that Nancy Brinker stepped down and the new CEO makes less. I checked on Charity Navigator yesterday and Nancy Brinker still was paid over $400,000 per year in the last set of financials reported (it was either 2014 or 2015) and she is not even CEO!!! She is the Chair of Strategy. The CEO makes less than her. The fact that she has become a multimillionaire by profiting off her sister's cancer death leaves a bad taste in my mouth. I am all about people making money in life but that ambition should not be carried out in the non-profit world. It just seems wrong.
  • nihahi
    nihahi Member Posts: 3,841
    edited September 2016

    The statement regarding Planned Parenthood is offensive, based on political rhetoric, extremely biased to "conservative" views, and completely lacking in factual information or scope of PP contribution to women's health issues.

  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    Please, the post that Ally46 shared is from an unreliable source - http://www.chrisbeatcancer.com/shocking-facts-abou...

    While we might enjoy kicking it around here, we will get laughed at, if we take it as pure fact, not speculation by an unreliable source that profits from fooling folks.

    If we want to build a strong case for the 5% of cancer research funding goes to MBC argument, please let's rely on more reliable sources.

    Unfortunately the ECCO article that I shared earlier about 5% of cancer research funding is neither MBC specific, US oriented nor recently updated. And it tells us NOTHING about Komen's funding of breast cancer research.

    I've quoted and linked to additional sources below. Each source is separated by xxx, a single x separates quotes from that source.

    xxx

    Metastatic Breast Cancer Network (MBCN) shares the source of the 5% of cancer research funding going to MBC:

    METASTATIC RESEARCH FUNDING: Estimated to be around 5% in Europe and less than that in US for metastatic research for ALL cancers. [Steeg, Patricia and Sleeman, Jonathan. "Cancer metastasis as a therapeutic target" European Journal of Cancer 46 (2010) 1177-1180.

    xxx

    Metavivor is a big proponent of 30% (of breast cancer research funding) for 30% - because 30% of those with breast cancer have or will later have MBC. http://www.metavivor.org/blog/mbc-statistics-revis...

    This is from the Metavivor website:

    2014 Update: The 5 percent figure appeared in the article "Cancer Metastasis as a Therapeutic Target" written by Patricia S. Steeg PhD and Jonathan Sleeman PhD. The figure was derived by analyzing reports and scanning for key words such as metastasis, dissemination, progression and invasion; thus the figure includes research to prevent metastasis and study the progression to metastasis as well as to control, stop or otherwise impact a metastasis that has already occurred. Country statistics ranged from a high of 11 percent in Switzerland to a low of 2.3 percent in the US. The entire article can be read in the European Journal of Oncology, 46th edition, pages 1177 – 1180 published in 2010. Steeg Sleeman Report

    So where does most of the money go? It goes predominantly into prevention and early detection. If one looks at the funding distribution pie charts of various organizations, these two categories are inevitably included. What is not immediately apparent is that much of the funding designated for other categories, such as biology and etiology, is also spent on issues pertaining to prevention and early detection. By comparison, MBC research is so poorly funded that it rarely even appears on a pie chart.

    xxx

    We're getting closer!

    Here's Snopes on:

    Rumor: The Susan G. Komen breast cancer organization only gives 20% of their donations to cancer research and pays their CEO $684,000 per year.


    The reference to Komen's applying only 20% of donated money to breast cancer research likely comes from a pie chart displayed in the "Use of Funds" section of Wikipedia's article about Susan G. Komen for the Cure, which shows Komen's 2009-2010 Expenses: pie chart at link above.

    x

    While it may be true (or have recently been true) that breast cancer research comprises only a 21% share of Komen's program expenses, citing that figure as a criticism of the organization reflects a common misbelief that groups dedicated to addressing particular diseases (e.g., the Muscular Dystrophy Association, the ALS Association) exist solely or primarily to fund and direct research into curing and/or preventing those diseases. This perception is inaccurate: Komen and other groups like it have goals that include delivering a wide array of services to the communities they support beyond the funding of research, such as funding educational awareness and outreach programs, providing screening and diagnostic procedures, and arranging medical treatment and home care for persons currently living with those diseases.

    A more relevant metric for assessing a charity's overall financial effectiveness is the percentage of the organization's budget that is actually spent on all the programs and services the charity delivers, and in this area the Charity Navigator charity evaluation site gives Komen an 80.3 rating (as well as a 96.0 rating for Accountability & Transparency). Charity Navigator does rank many other breast cancer charities higher than Susan G. Komen for the Cure, however.

    x

    And about that Planned Parenthood rumor - Komen reversed that decision after being criticized in 2012:

    In 2012, Komen founder and CEO Nancy Brinker became the focus of controversy when she announced Komen would be pulling the grants the organization had been providing to Planned Parenthood for breast cancer screenings, then quickly reversed that decision.

    xxx

    Breast Cancer Action has been continuously critical of pink ribbons, profiteering, Komen and research funding priorities.

    Here's just one report on The Cancer Industry

    Excerpt on funding for breast cancer research:

    Breast cancer research is a multibillion-dollar industry. In just one year of funding — 2007 — the National Cancer Institute (NCI) spent $572.4 million on breast cancer research. That same year, the National Institutes of Health (NIH) spent an additional $705 million. The Susan G. Komen for the Cure Foundation had total revenues that year of nearly $162 million. The Komen organization also claimed in 2007 that it had invested nearly $1 billion in breast cancer since its founding in 1980.

    This is only the tip of the breast cancer research funding iceberg. You've heard of the Komen Foundation and the NCI, but very few people know about the hundreds of organizations that raise funds in the name of breast cancer research, or the private companies that invest in and pursue new drugs and devices for use in diagnosis and treatment.

    A Google search for "breast cancer research funding organizations" turns up hundreds of results. At the federal government level alone, over 30 federal agencies are funding or conducting breast cancer research.

    So, not only is a great deal of money being spent on breast cancer research, but hundreds of agencies are spending it.

    Unfortunately, the work of these organizations is not coordinated. There is no way to tell whether the work being done by one research entity has already been done by another, or whether one set of researchers is in touch with others who might help advance its ideas. And very few research organizations are transparent about what they are researching or what the outcomes of that research might be, particularly when the results are negative.

    Given the enormous cost of cancer research (researchers seek grants in the hundreds of thousands of dollars), the stunning amount of money devoted to it, and the lack of coordination among the researcher groups, it's impossible to know whether an individual's gift will be well spent — or make any difference at all.

    This doesn't mean you can't do anything about research. Breast Cancer Action is making a positive impact on breast cancer research by:

    • Pushing the researchers to find both less toxic treatments and true preventive measures.
    • Advocating for research that doesn't simply focus on genes and biology but also includes social, racial, and economic injustices as root causes of breast cancer.

    We report to our supporters on what is happening in research. and how they can make a difference in moving research in the best direction so that affected communities are represented and protected.

    BCAction is the leader in transparency and accountability in the breast cancer world. When you make a gift to Breast Cancer Action, you'll know exactly where your money is going and what it's accomplishing. As the only national breast cancer organization that refuses to accept funding from companies profiting from or contributing to cancer, Breast Cancer Action is able to be very clear about what is — and isn't — happening in breast cancer research. And, because we're effective activists, we know how to make happen what needs to happen to save lives.

    So, the next time you write a check to advance breast cancer research, consider writing it to Breast Cancer Action.

    Breast Cancer Action is a big supporter of the Think Before You Pink campaign.

    xxx

    Friends, I hope this is helpful...it does seem like we're repeating the same old, same old and that it may be time to update our sources, so we can make strong arguments for more and better funding for metastatic breast cancer research funding. I've read hundreds of medical journal abstracts, articles and press releases in the 20+ years I've been living with advanced breast cancer.

    It embarrasses me when we use unreliable sources (resources) to support our claims for equity. Surely we and our allies can do better at finding and sharing more reliable, accurate and up-to-date facts and figures.

    As advocates and activists we can work together to promote our shared cause!

    Healing regards all, Stephanie

  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    To finish this cycle of thought - when talking about Komen and the Pink Industry to those who really, really believe in them, we might want more talking points!

    The Think Before You Pink website is a great place to begin.

    And here's a must-see film for building critical arguments - Pink Ribbons, Inc. out of Canada, but I recognize many from the USA.

    The trailer



    watch it free

    Those interested in MBC should be sure to look for the kick-ass Stage IV women's support group. They are phenomenal.

    I don't bother to boycott Pinktober, because I don't buy many products and they wouldn't miss my unspent dollars, but I don't buy promises of the breast cancer industry.

    In 2010, I wasn't surprised that Komen was able to trademark the phrase "for the cure" and then legally stopped over 100 charities for using it in their fundraising efforts:

    Susan G. Komen Foundation Elbows Out Charities Over Use Of The Word 'Cure'

    They do have a trademark on the running pink ribbon, but I'd heard years ago that they tried to claim ownership of pink=breast cancer. I can't find a link to that story and wonder if it was an internet rumor like the Planned Parenthood story where Komen first pulled funds on PP, then re-allocated them in the face of criticism.

    Here's a longer story about the evolution of the pink ribbon from a peach ribbon, from a small founder to a huge industry:

    In Memoriam: Charlotte Haley, Creator of the First (Peach) Breast Cancer Ribbon

    Basically, there's a lot to reflect on when deciding which breast cancer organizations deserve our support.

    But, I haven't found any concrete evidence about how much of the Komen funds go to clinical or trial research/ for MBC.

    Friends, I hope others provide your own thoughts and findings. This it's a good opportunity to self-educate and share what we've learned with one another and the wider world.

    best, Stephanie

  • JeninMichigan
    JeninMichigan Member Posts: 2,974
    edited September 2016

    Stephanie

    Thank you so much for all the information. It is hard to nail down Komen on the percent they dedicate to metastatic breast cancer research and probably by design. The fact of the matter is that they patent "for the cure" and yet at most 21% of the money they raise go to the research. How is this "for the cure"? Yeah you gave $375,000 to the Metastatic Breast Cancer Project but that is $25,000 less than Susan's sister makes annually. Seriously, cancer is big business and Komen is big business. All that deal with them are lining their pockets and can also pretend to feel good about themselves for doing so.

    Thanks again. Your insight is so valuable.

    Jennifer

  • Longtermsurvivor
    Longtermsurvivor Member Posts: 1,438
    edited September 2016

    (((Jen)))

    So pleased you're representing us as an advocate and activist.

    Thank you, Stephanie

  • TwoHobbies
    TwoHobbies Member Posts: 2,118
    edited September 2016

    Jen, I suppose you have already found their tax returns (990). http://ww5.komen.org/AboutUs/FinancialInformation....

    I don't think you can tell how much is going to MBC research, although you can see how much is spent or granted to research. The descriptions are too general to know if its MBC related or other research. It is discouraging to see how much their salaries are. I guess we are in the wrong business!

Categories